The Robert Connor Dawes (RCD) Foundation. We're supporting paediatric brain cancer matters in areas of Research, Care & Development #aeternumfortis#ConnorsRun
Proud to see this research published in Nature and to be acknowledged as part of the global effort accelerating progress in ependymoma.
This is what collaboration looks like.
New @Nature study shows that androgens keep PFA ependymoma cells in a less‑developed, growth‑prone state—explaining why the tumor is more common in boys. Blocking this pathway slowed tumor growth in models, pointing to a possible therapeutic direction.
🔗https://t.co/0nB5yuQjc7
Proud to support early-career talent: Dr. Siri Ippagunta (@StJude@StJudeResearch) is the 2026 CERN & Robert Connor Dawes Fellow.
Together, we’re building momentum against #ependymoma.
Learn more: https://t.co/XRja37Cjnh
@CERNfoundation@_RCDFoundation
We're proud to see the first person in Australia to enlist in this innovative trial. We are so proud to be part of the TarGeT collaborative team bringing cutting-edge research to patients in clinical trials.
https://t.co/mzT6I6bks2
A major milestone for paediatric brain cancer research. The TarGeT clinical trial is now open and enrolling its first patient at The Royal Children’s Hospital, Melbourne and Perth Children’s Hospital. Proud to be part of the TarGeT Collaborative. https://t.co/vwAzSoF0PM
📽️ In Part 2 of FivepHusion's business opportunity showcase, CEO Christian Toouli outlines the Company's strong IP & pipeline, including drug pricing and revenue projections.
@FivepHusion
📽️ FivepHusion's CEO joins TMB to discuss the scientific and clinical rationale for the company, focused on their lead asset Deflexifol®.
Across this series we discuss the Company's science, business fundamentals, differentiation and investment opportunity.
@FivepHusion
Emotions have continued to swirl among teammates of Essendon captain Zach Merrett following his meeting with Sam Mitchell. https://t.co/5zYfOfGqUb @XanderMcGuire7#7NEWS
A big-hearted THANK YOU to everyone who made this happen.
Over $1.7 million raised during our 2024 Connor's Run campaign, to help change the odds for young people impacted by brain cancer.
https://t.co/6Lake8RT9L
Fantastic live coverage at the Connor's Run 18.8km start in Hampton on Sunday with @lizdawes62 and ambassador Jack Watts. Thank you Today!
https://t.co/CjULz3xUA7
We're proud to announce Dr Samreen Shaikh @UQ_News has received the 2024 @CERNfoundation and Robert Connor Dawes Foundation Scientific Fellowship Award- with @NBTStweets
Learn more: https://t.co/bRZ9cYIVKv
On Sunday the team from our Centre for Cancer Research took part in Connor’s Run to show their support for the courageous children battling brain cancer & to fund the research needed to ultimately eradicate paediatric brain cancer 🙌
@_RCDFoundation
Are you coming to Canberra this year? Last year was a huge success and provided an amazing opportunity to connect with the brain tumour community and policy makers. For all of the details go to https://t.co/iXXyeNhduk all the links are on the home page. #BTSM
Our third Ependymoma Science meeting was held this July in Cambridge, UK. This meeting was funded by the major sponsor the Robert Connor Dawes @_RCDFoundation with support from @TexasChildrens Hospital and @CrukCBTCE@ICR_London
A new cancer therapy that melts tumours from within could be a breakthrough for incurable brain cancer, if it is successful in clinical trials. > https://t.co/OiB4vS1i8R
Our 9.30am St Kilda start has sold out!
Spots are still available for our 8am St Kilda start, and our 8am 18.8km Hampton start (although they are selling fast), and our new 10.30am 3km Little Bird Loop.
Register now: https://t.co/6Lake8RT9L